Clinical Trial Update: A Study to Explore Efficacy and Safety of ASP015K in Subjects With Moderate to Severe Psoriasis [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy and safety of ASP015K in adults with moderate to severe psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• ASP015K

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Psoriasis | Phase 2 | Status: COMPLETED